University Hospital Basel
Basel, Switzerland
44 recruiting
Showing 1–20 of 123 trials
Recruiting
Not Applicable
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome
Primary polydipsiaArginine vasopressin deficiency
University Hospital, Basel, Switzerland144 enrolled1 locationNCT07569861
Recruiting
Not Applicable
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Atrial FibrillationIschemic Stroke
Insel Gruppe AG, University Hospital Bern482 enrolled29 locationsNCT05976685
Recruiting
Phase 4
The Basel BOMP-AID Randomized Trial
Hypoactive Delirium
University Hospital, Basel, Switzerland190 enrolled1 locationNCT03438526
Recruiting
Phase 4
Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor
Bleeding
University Hospital, Basel, Switzerland120 enrolled1 locationNCT04555785
Recruiting
Not Applicable
Wheat Beer for Prevention of Delirium in Intensive Care Patients
ICU delirium
University Hospital, Basel, Switzerland380 enrolled1 locationNCT04876742
Recruiting
Phase 2
Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.
Patellofemoral osteoarthritis
University Hospital, Basel, Switzerland75 enrolled9 locationsNCT06163573
Recruiting
BEAT-SHOCK Registry
Cardiogenic ShockMyocardial Infarction (MI)Acute Decompensated Heart Failure+4 more
University Hospital, Basel, Switzerland8,000 enrolled1 locationNCT07643610
Recruiting
Phase 2
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor
CatalYm GmbH131 enrolled25 locationsNCT07246863
Recruiting
Not Applicable
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
Lymphedema, Breast Cancer
University Hospital, Basel, Switzerland280 enrolled36 locationsNCT05890677
Recruiting
Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Multiple Myeloma
European Myeloma Network B.V.1,594 enrolled212 locationsNCT05243797
Recruiting
Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled561 locationsNCT07165028
Recruiting
Not Applicable
The PERSEVERE Study
Pulmonary EmbolismPulmonary Thromboembolism
Inari Medical200 enrolled26 locationsNCT06588634
Recruiting
Not Applicable
Reduce Tobacco Use in People Living With HIV in Switzerland
SmokingHIV
University Hospital, Basel, Switzerland972 enrolled7 locationsNCT06789692
Recruiting
Phase 3
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
Non-small Cell Lung Cancer
ETOP IBCSG Partners Foundation390 enrolled33 locationsNCT06931717
Recruiting
Phase 2
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation44 enrolled18 locationsNCT05718323
Recruiting
Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Crohn's Disease
Takeda396 enrolled138 locationsNCT06227910
Recruiting
WATCHMAN FLX Pro European Registry
Left Atrial Appendage ClosureNon-valvular Atrial Fibrillation (AF)
Boston Scientific Corporation1,000 enrolled13 locationsNCT07262255
Recruiting
Phase 3
Vorasidenib Maintenance for IDH Mutant Astrocytoma
IDH-mutant Grade 2 or 3 Astrocytoma
European Organisation for Research and Treatment of Cancer - EORTC468 enrolled33 locationsNCT06809322
Recruiting
Pilot Observational Study of an Integrative Cure Stay Program
Breast CancerGynecologic Cancer
University Hospital, Basel, Switzerland30 enrolled1 locationNCT07398079
Recruiting
Phase 2Phase 3
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation534 enrolled68 locationsNCT04910685